Hyperfine HYPR
NASDAQ HYPR
$0.79 -0.03 (-3.57%)
As of: Sep 9, 2026 · 3:25 PM EDT

Hyperfine (HYPR) EBITDA Margin Growth (1y) (2022 - 2026)

Analysis

Hyperfine (HYPR) EBITDA Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 GE HealthCare Technologies 29.64 Bn 27.53 Bn 2.18 Bn 89.00
2 Lantheus Holdings 6.58 Bn 5.98 Bn 241.86 Mn 255.00
3 Heartflow 4.05 Bn 3.68 Bn 53.19 Mn 365.00
4 Neogen 2.57 Bn 2.39 Bn 107.80 Mn 27,242.00
5 Butterfly Network 1.97 Bn 1.84 Bn 23.29 Mn 2,695.00
6 Ceribell 926.46 Mn 797.20 Mn 25.94 Mn -58.00
7 QuidelOrtho 871.90 Mn 748.50 Mn - -
8 Varex Imaging 779.06 Mn 679.86 Mn 76.70 Mn 5,059.00
9 Prenetics Global 340.62 Mn 281.57 Mn 30.20 Mn 2,655.00
10 Hyperfine 79.11 Mn 34.35 Mn 1.98 Mn 13,897.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13,897.00
Mar 31, 2026 29,089.00
Dec 31, 2025 31,894.00
Sep 30, 2025 4,140.00
Jun 30, 2025 -5,719.00
Mar 31, 2025 -18,694.00
Dec 31, 2024 -3,086.00
Sep 30, 2024 20,374.00
Jun 30, 2024 4,711.00
Mar 31, 2024 17,147.00
Dec 31, 2023 52,414.00
Sep 30, 2023 6,099.00
Jun 30, 2023 116,704.00
Mar 31, 2023 108,059.00
Dec 31, 2022 502,616.00
Sep 30, 2022 385,212.00
Jun 30, 2022 256,145.00
Mar 31, 2022 78,272.00